Post by Wyss Institute at Harvard University

Wyss startup Dyno Therapeutics is developing optimized AAVs to enable a new generation of more effective, safer gene therapies across a large spectrum of diseases. They are focused on becoming a leading gene therapy delivery partner and enabling other companies across the ecosystem to bring gene therapies to patients https://lnkd.in/edzkVZSM